- Home
- BMBL vs LRMR Comparison
BMBL vs LRMR Comparison
Compare BMBL & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMBL | LRMR |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 417.4M | 455.8M |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | BMBL | LRMR |
|---|---|---|
| Price | $2.87 | $3.93 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 6 |
| Target Price | $4.46 | ★ $16.50 |
| AVG Volume (30 Days) | ★ 4.0M | 2.9M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.34 | N/A |
| Revenue | ★ $965,658,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1,816.14 |
| P/E Ratio | $8.62 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.54 | $2.72 |
| 52 Week High | $8.63 | $6.42 |
Technical Indicators
Market Signals| Indicator | BMBL | LRMR |
|---|---|---|
| Relative Strength Index (RSI) | 41.84 | 56.67 |
| Support Level | $2.64 | $3.87 |
| Resistance Level | $3.23 | $4.32 |
| Average True Range (ATR) | 0.17 | 0.28 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 2.42 | 69.47 |
Price Performance
Historical ComparisonAbout BMBL Bumble Inc.
Bumble Inc is engaged in offering online dating services. The platform enables people to connect and build healthy and equitable relationships on their own terms. The company operates two apps, Bumble and Badoo, where users come every month to discover new people and connect. The company operates as one operating segment with revenue derived in the form of recurring subscriptions and in-app purchases. The company operates in USA, which derives maximum revenue; and Rest of the World.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.